Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

DECIPHERA PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 30

FDA approve VIMSELTINIB

Comment Full text

RISING

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 31

FDA approve LINEZOLID

Comment Full text

MYLAN

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 30

FDA approve MERCAPTOPURINE

Comment Full text

TARO

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 30

FDA approve RISPERIDONE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 30

FDA approve ETHINYL ESTRADIOL; ETONOGESTREL

Comment Full text

ORBION PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 27

FDA approve ARIPIPRAZOLE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 32

FDA approve NAPROXEN

Comment Full text

ABBVIE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 24

FDA approve AVIBACTAM SODIUM; AZTREONAM

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 29

FDA approve OXCARBAZEPINE

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 31

FDA approve BROMFENAC SODIUM

Comment Full text
  • Previous
  • 99
  • 100
  • 101
  • 102
  • 103
  • Next

Search

News categories

  • Technical Exchange News(9543)
  • Event(407)
  • SEC News(156494)
  • FDA Approval(8929)
  • Company Report(721)
  • Business News(106215)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin